T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation - PubMed (original) (raw)
Case Reports
. 2001 May 1;97(9):2896-9.
doi: 10.1182/blood.v97.9.2896.
N Oda, K Yamaguchi, N Kawamura, H Kikuta, S Taniuchi, Y Kobayashi, K Terada, H Ikeda, M S Hershfield, K Kobayashi, Y Sakiyama
Affiliations
- PMID: 11313286
- DOI: 10.1182/blood.v97.9.2896
Free article
Case Reports
T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation
T Ariga et al. Blood. 2001.
Free article
Abstract
Inherited deficiency of adenosine deaminase (ADA) results in one of the autosomal recessive forms of severe combined immunodeficiency. This report discusses 2 patients with ADA deficiency from different families, in whom a possible reverse mutation had occurred. The novel mutations were identified in the ADA gene from the patients, and both their parents were revealed to be carriers. Unexpectedly, established patient T-cell lines, not B-cell lines, showed half-normal levels of ADA enzyme activity. Reevaluation of the mutations in these T-cell lines indicated that one of the inherited ADA gene mutations was reverted in both patients. At least one of the patients seemed to possess the revertant cells in vivo; however, the mutant cells might have overcome the revertant after receiving ADA enzyme replacement therapy. These findings may have significant implications regarding the prospects for stem cell gene therapy for ADA deficiency.
Similar articles
- Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype.
Moncada-Vélez M, Vélez-Ortega A, Orrego J, Santisteban I, Jagadeesh J, Olivares M, Olaya N, Hershfield M, Candotti F, Franco J. Moncada-Vélez M, et al. Scand J Immunol. 2011 Nov;74(5):471-81. doi: 10.1111/j.1365-3083.2011.02593.x. Scand J Immunol. 2011. PMID: 21671975 Free PMC article. - Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
Arredondo-Vega FX, Kurtzberg J, Chaffee S, Santisteban I, Reisner E, Povey MS, Hershfield MS. Arredondo-Vega FX, et al. J Clin Invest. 1990 Aug;86(2):444-52. doi: 10.1172/JCI114730. J Clin Invest. 1990. PMID: 1974554 Free PMC article. - Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency.
Ariga T, Oda N, Sanstisteban I, Arredondo-Vega FX, Shioda M, Ueno H, Terada K, Kobayashi K, Hershfield MS, Sakiyama Y. Ariga T, et al. J Immunol. 2001 Feb 1;166(3):1698-702. doi: 10.4049/jimmunol.166.3.1698. J Immunol. 2001. PMID: 11160213 - Normal and mutant human adenosine deaminase genes.
Akeson AL, Wiginton DA, Hutton JJ. Akeson AL, et al. J Cell Biochem. 1989 Mar;39(3):217-28. doi: 10.1002/jcb.240390302. J Cell Biochem. 1989. PMID: 2651461 Review. - Adenosine deaminase: functional implications and different classes of inhibitors.
Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Cristalli G, et al. Med Res Rev. 2001 Mar;21(2):105-28. doi: 10.1002/1098-1128(200103)21:2<105::aid-med1002>3.0.co;2-u. Med Res Rev. 2001. PMID: 11223861 Review.
Cited by
- Reversion Mosaicism in Primary Immunodeficiency Diseases.
Miyazawa H, Wada T. Miyazawa H, et al. Front Immunol. 2021 Nov 16;12:783022. doi: 10.3389/fimmu.2021.783022. eCollection 2021. Front Immunol. 2021. PMID: 34868061 Free PMC article. Review. - Case Report: A Novel IL2RG Frame-Restoring Rescue Mutation Mimics Early T Cell Engraftment Following Haploidentical Hematopoietic Stem Cell Transplantation in a Patient With X-SCID.
Steininger J, Leiss-Piller A, Geier CB, Rossmanith R, Elfeky R, Bra D, Pichler H, Lawitschka A, Zubarovskaya N, Artacker G, Matthes-Leodolter S, Eibl MM, Wolf HM. Steininger J, et al. Front Immunol. 2021 Apr 20;12:644687. doi: 10.3389/fimmu.2021.644687. eCollection 2021. Front Immunol. 2021. PMID: 33959125 Free PMC article. - Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.
Gruber C, Bogunovic D. Gruber C, et al. Hum Genet. 2020 Jun;139(6-7):745-757. doi: 10.1007/s00439-020-02131-9. Epub 2020 Feb 17. Hum Genet. 2020. PMID: 32067110 Free PMC article. Review. - Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells.
Pouzolles M, Machado A, Guilbaud M, Irla M, Gailhac S, Barennes P, Cesana D, Calabria A, Benedicenti F, Sergé A, Raman I, Li QZ, Montini E, Klatzmann D, Adjali O, Taylor N, Zimmermann VS. Pouzolles M, et al. J Allergy Clin Immunol. 2020 Feb;145(2):679-697.e5. doi: 10.1016/j.jaci.2019.08.029. Epub 2019 Sep 9. J Allergy Clin Immunol. 2020. PMID: 31513879 Free PMC article. - Somatic genetic rescue in Mendelian haematopoietic diseases.
Revy P, Kannengiesser C, Fischer A. Revy P, et al. Nat Rev Genet. 2019 Oct;20(10):582-598. doi: 10.1038/s41576-019-0139-x. Epub 2019 Jun 11. Nat Rev Genet. 2019. PMID: 31186537 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials